Evaluates protein expression enhancements in E. coli, suggesting a low-cost production platform for functional Mfps.
. The absence of net charged residues, rather than the copy number or the predicted α-helical structure of the T7B9M3 tag, contributes to the solubility enhancement. T7B9M3-fp-3B achieved a 365.96 mg/L soluble protein titer with a 98.75% soluble rate in a shake flask. Coupling the tyrosinase coexpression to endow Mfps with a dopaminization capability, the tyrosine hydroxylation efficiency reached 19.82%. Moreover, dopanized-Mfps tended to form stronger interactions with various substrates, including glass, polypropylene, and polyethylene, than the unmodified version. Our findings suggest that the combined strategy may contribute to establishing a scalable and low-cost protein expression platform with the potential for batch production of functional Mfps.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: